This suggests that SAMHD1 mutations contribute to the elevation of intracellular dNTP levels commonly observed in cancer cells [208] and mechanistically connects the respective roles of SAMHD1 in cancer and HIV-1 restriction [208]. The gene discussed is SAMHD1; the disease is cancer.